In contrast, negative immunoreactivity to these markers, combined with reactivity to CK7, CD10 and vimentin, in conjunction with negative clinical and biological thyroid investigations and absence of metastatic disease, allowed us to exclud the possibility of metastatic thyroid follicular carcinoma in our case. This evidence concerns the gene MME and thyroid gland disorder.